Cited in boardrooms, legal proceedings & government briefings since 2017
Asia, the world’s most populous continent, has a relatively low prevalence of cannabis use at just 2% annually.
Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.
Trusted by teams at
Asia, the world’s most populous continent, has a relatively low prevalence of cannabis use at just 2% annually. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.
delivery format
2019
published
Our first report on the Asian cannabis industry explores the intersection of government policy and research and the impact of international legislative developments on the region’s burgeoning cannabis industry. While some countries still take a draconian view and impose the death penalty for even minor drug misdemeanours, others, such as Myanmar, are working closely with the UN to change the approach of law en-forcement agencies to regard drugs as a public health issue rather than one for the criminal justice system. As our report demonstrates, cannabis use is deeply rooted in some of the region’s ancient medical practices, and we expect to see medicinal cannabis gain favour ahead of any acceptance of recreational. Asian Insights Market Overivew
Investors & analysts
Defensible sizing and forecasts to underwrite the thesis.
Corporate strategy & FMCG
Opportunity sizing and entry routes across key markets.
